Recruiting Lymphoma Studies in Dallas
Safety and Efficacy of Epcoritamab With Gemcitabine, Dexamethasone, and Cisplatin (GDP) Salvage Chemotherapy in Relapsed Refractory Large B-cell Lymphoma
Subjects with relapsed large cell lymphoma will receive 3 cycles of combination therapy consisting of GDP and epcoritamab. Each cycle will last 21 days. GDP consists of gemcitabine 1000 mg/m2 IV on Da...
T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)
This is an open-label, dose escalation, multi-center, Phase I/II clinical trial to assess the safety of an autologous T-cell therapy (EB103) and to determine the Recommended Phase II Dose (RP2D) in ad...
About Lymphoma Clinical Trials in Dallas
Lymphoma is a cancer of the lymphatic system that affects infection-fighting cells called lymphocytes. The two main types are Hodgkin lymphoma and non-Hodgkin lymphoma. Treatment often includes chemotherapy, radiation, immunotherapy, and in some cases stem cell transplant.
There are currently 2 lymphoma clinical trials recruiting participants in Dallas, TEXAS. These studies are seeking a combined 53 participants. Research is being sponsored by Dipenkumar Modi, Estrella Biopharma, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Lymphoma Clinical Trials in Dallas — FAQ
Are there lymphoma clinical trials in Dallas?
Yes, there are 2 lymphoma clinical trials currently recruiting in Dallas, TEXAS. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Dallas?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Dallas research site will contact you about next steps.
Are clinical trials in Dallas free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Dallas studies also compensate for your time and travel.
What lymphoma treatments are being tested?
The 2 active trials in Dallas are testing new therapies including novel drugs, biologics, and treatment approaches for lymphoma.
Data updated March 2, 2026 from ClinicalTrials.gov